Compare StocksIEX vs JNJ

IDEX Corporation (IEX) vs Johnson & Johnson (JNJ): Which Is the Better Buy in 2026?

As of 2026-09-17, IEX is overvalued at $223, with a DCF intrinsic value of $180 and a margin of safety of -24%. JNJ is fairly valued at $268, with an intrinsic value of $303 and a margin of safety of 11%. Of the two, JNJ has the wider margin of safety.

IEX
IDEX Corporation
$222.64
VS
JNJ
Johnson & Johnson
$268.05

Rewards

IEX
  • IDEX Corporation scores 84/100 on the Economic Moat Score (Wide Moat), with margin stability as the strongest competitive dimension.
  • Altman Z-Score of 4.68 indicates very low bankruptcy risk — the company is firmly in the safe zone.
JNJ
  • Johnson & Johnson has maintained ROIC above 15% for 4 consecutive years, indicating a durable competitive advantage.
  • Gross margin of 68.1% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • Johnson & Johnson scores 90/100 on the Economic Moat Score (Wide Moat), with revenue predictability as the strongest competitive dimension.

Risks

IEX
    JNJ
    • FCF yield of 2.6% is below 3%, meaning the market is pricing in substantial future growth to justify the current price.
    • Trailing P/E of 31.1x is 56% above the historical average of 20.0x — the stock trades at a premium to its own history.
    • PEG ratio of 2.80 indicates the stock is expensive relative to its expected growth — the market may be pricing in more growth than analysts project.

    Key Valuation Metrics

    Learn more →
    IEX
    JNJ
    Valuation
    $555.61M
    Free Cash Flow
    $16.89B
    3.39%
    FCF Yield
    2.61%
    31.99
    Trailing P/E
    31.06
    23.13
    Forward P/E
    21.82
    Quality & Moat
    10.66%
    ROIC
    16.85%
    12.96%
    ROE
    25.74%
    44.73%
    Gross Margin
    68.14%
    1.68
    PEG Ratio
    2.80
    Balance Sheet Safety
    0.32
    Net Debt / Equity
    0.33
    N/A
    Interest Coverage
    N/A
    1.31
    Net Debt / EBITDA
    0.81
    1.32%
    Dividend Yield
    2.01%
    IEX: 3Ties: 2JNJ: 7
    IEXJNJ

    Historical Fundamentals

    Learn more →
    IEX

    Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

    JNJ

    Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

    Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

    $1 Retained Earnings Test

    Learn more →
    IEX
    $-4.09
    created per $1 retained over 3 years
    Market Cap Declined
    Σ Retained
    $975.7M
    Δ Market Cap
    $-3.99B
    Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
    > $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
    JNJ
    $0.91
    created per $1 retained over 3 years
    Mediocre Allocator
    Σ Retained
    $40.05B
    Δ Market Cap
    +$36.63B
    Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
    > $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

    Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
    > $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

    Discounted Cash Flow (DCF) Analysis

    Learn more →
    IEX
    23.7% Overvalued
    Price is 23.7% above estimated fair value
    Current Price: $222.64
    Fair Value: $179.94
    Strongly undervalued
    Undervalued
    Fairly valued
    Overvalued
    Strongly overvalued
    JNJ
    11.4% Margin of Safety
    Price is 11.4% below estimated fair value
    Current Price: $268.05
    Fair Value: $302.57
    Strongly undervalued
    Undervalued
    Fairly valued
    Overvalued
    Strongly overvalued

    Reverse DCF — Market-Implied Growth

    Learn more →
    IEX

    What growth rate is the market pricing in at $223?

    +12.4%
    Market-Implied Owner Earnings Growth
    Standard FCF implies +14.0%

    The market implies +12.4% Owner Earnings growth, above historical trends.

    Standard FCF implies a demanding +14.0%, reflecting heavy growth investment.

    JNJ

    What growth rate is the market pricing in at $268?

    +9.7%
    Market-Implied Owner Earnings Growth
    Standard FCF implies +17.1%

    The market implies +9.7% Owner Earnings growth, above historical trends.

    Standard FCF implies a demanding +17.1%, reflecting heavy growth investment.

    Economic Moat Score

    Learn more →
    IEX
    84/100
    Wide Moat
    70+ Wide · 40-69 Narrow · <40 None

    Wide moat with strength across all dimensions. Margin Stability is the standout factor.

    Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.
    JNJ
    90/100
    Wide Moat
    70+ Wide · 40-69 Narrow · <40 None

    Wide moat with strength across all dimensions. Revenue Predictability is the standout factor.

    Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 5 years of fundamental data.

    Forensic Accounting

    Learn more →
    IEX
    -2.53
    Unlikely Manipulator
    Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

    M-Score Trend

    Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
    JNJ
    -2.31
    Unlikely Manipulator
    Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

    M-Score Trend

    Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

    Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

    Ownership Breakdown

    Learn more →
    IEX
    Insiders 0.2%Institutions 105.4%
    No. of Institutional Holders1,015
    High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
    JNJ
    Insiders 0.1%Institutions 76.7%Retail & Other 23.2%
    No. of Institutional Holders5,826
    High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

    High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

    Insider Buying Activity

    Learn more →
    IEX
    0
    Buys (3M)
    1
    Buys (12M)
    Total value (12M): $101,647
    CHRISTENSON CARL R
    Director
    $101,647
    @ $169.41 · 2025-11-05
    HELMKAMP KATRINA L.
    Director
    $399,026
    @ $159.61 · 2025-08-07
    Open market purchases · includes direct & indirect ownership · excludes option exercises
    JNJ
    0
    Buys (3M)
    1
    Buys (12M)
    Total value (12M): $257,688
    MORIKIS JOHN G
    Director
    $257,688
    @ $206.15 · 2025-11-26
    WEINBERGER MARK A
    Director
    $147,220
    @ $147.22 · 2024-12-12
    Open market purchases · includes direct & indirect ownership · excludes option exercises

    Open market purchases · includes direct & indirect ownership · excludes option exercises.

    Insider Selling Activity

    Learn more →
    IEX
    1
    Sells (3M)
    2
    Sells (12M)
    Total value (12M): $3.40M
    ANDERSON LISA M
    General Counsel
    $91,859
    @ $238.59 · 2026-08-12
    ASHLEMAN ERIC D
    Chief Executive Officer
    $3.31M
    @ $215.22 · 2026-05-11
    MAHENDRA AKHIL
    Chief Financial Officer
    $45,222
    @ $180.89 · 2025-06-05
    Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
    JNJ
    6
    Sells (3M)
    15
    Sells (12M)
    Total value (12M): $132.73M
    SCHMID TIMOTHY
    Officer
    $9.23M
    @ $274.74 · 2026-09-02
    TAUBERT JENNIFER L
    Officer
    $3.95M
    @ $263.36 · 2026-08-17
    DUATO JOAQUIN BOIX
    Chief Executive Officer
    $32.20M
    @ $261.17 · 2026-08-13
    FORMINARD ELIZABETH
    Officer
    $4.09M
    @ $257.00 · 2026-08-06
    DUATO JOAQUIN BOIX
    Chief Executive Officer
    $12.52M
    @ $258.15 · 2026-08-05
    BROADHURST VANESSA
    Officer
    $5.79M
    @ $251.27 · 2026-07-20
    WENGEL KATHRYN E
    Chief Technology Officer
    $2.41M
    @ $241.15 · 2026-06-11
    DECKER ROBERT J
    Officer
    $1.01M
    @ $247.87 · 2026-02-27
    SCHMID TIMOTHY
    Officer
    $324,763
    @ $245.66 · 2026-02-20
    SCHMID TIMOTHY
    Officer
    $5.53M
    @ $244.33 · 2026-02-18
    REED JOHN C
    Officer
    $13.11M
    @ $243.00 · 2026-02-17
    WOLK JOSEPH J
    Chief Financial Officer
    $21.77M
    @ $242.80 · 2026-02-17
    SWANSON JAMES D
    Chief Technology Officer
    $15.11M
    @ $243.39 · 2026-02-17
    BROADHURST VANESSA
    Officer
    $1.51M
    @ $243.39 · 2026-02-17
    REED JOHN C
    Officer
    $4.19M
    @ $192.71 · 2025-10-17
    TAUBERT JENNIFER L
    Officer
    $10.04M
    @ $177.81 · 2025-09-04
    DUATO JOAQUIN BOIX
    Chief Executive Officer
    $22.55M
    @ $179.21 · 2025-08-22
    WOLK JOSEPH J
    Chief Financial Officer
    $2.98M
    @ $176.91 · 2025-08-15
    REED JOHN C
    Officer
    $3.13M
    @ $163.55 · 2025-07-17
    DECKER ROBERT J
    Officer
    $1.16M
    @ $165.88 · 2025-02-25
    SCHMID TIMOTHY
    Officer
    $62,928
    @ $156.15 · 2025-02-18
    WOLK JOSEPH J
    Chief Financial Officer
    $2.00M
    @ $153.89 · 2025-02-07
    Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

    Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

    🎭 Mr. Market's Mood

    Learn more →
    IEX
    FearGreed
    😐Neutral(56/100)

    "Market is pricing this stock without strong emotion in either direction"

    Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
    JNJ
    FearGreed
    😏Greed(67/100)

    "Market is optimistic — be cautious and ensure you have a margin of safety"

    Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

    Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

    ⚖️ Buffett Signal

    Learn more →
    IEX
    Awaiting DCF Data

    The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

    DCF Margin of Safety: N/AMr. Market's Mood: Neutral (56)
    JNJ
    Awaiting DCF Data

    The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

    DCF Margin of Safety: N/AMr. Market's Mood: Greed (67)
    View IEX Full AnalysisView JNJ Full Analysis

    Frequently Asked Questions: IEX vs JNJ

    Is IDEX Corporation or Johnson & Johnson more undervalued in 2026?

    Based on our discounted cash flow model, JNJ trades at a 11.4% margin of safety (intrinsic value $303 vs. price $268), compared to IEX's -23.7% margin of safety (intrinsic $180 vs. $223).

    Which stock has a wider economic moat, IDEX Corporation or Johnson & Johnson?

    JNJ scores 90/100 (Wide moat), while IEX scores 84/100 (Wide moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

    Which company has better free cash flow, IDEX Corporation or Johnson & Johnson?

    IDEX Corporation (IEX) generates a 3.4% free cash flow yield, compared to Johnson & Johnson's 2.6%. A higher FCF yield means the business converts more of its market value into cash that can be returned to shareholders or reinvested.

    Which stock has higher return on invested capital, IDEX Corporation or Johnson & Johnson?

    JNJ earns 16.9% ROIC versus IEX's 10.7%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.

    Which dividend is safer, IDEX Corporation's or Johnson & Johnson's?

    IEX's dividend earns a safety score of 94/100 (Very Safe), compared to JNJ's 79/100 (Safe). IEX has raised its dividend for 3 consecutive years.

    IEX vs JNJ: Which Is the Better Buy in 2026? | SafetyMargin.io